CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- Open-market buys, last 90 days
- $291,587
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$291,587. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-10 | KUMAR AMIT Chief Executive Officer | Purchase | +5,000 | $3.04 | $15K | 635,812 |
| 2026-06-16 | Titterton Lewis H jr Director | Purchase | +2,836 | $2.64 | $7K | 972,170 |
| 2026-06-12 | KUMAR AMIT Chief Executive Officer | Purchase | +21,000 | $2.50 | $53K | 630,812 |
| 2026-01-28 | Baskies Arnold M Director | Purchase | +10,000 | $3.04 | $30K | 135,000 |
| 2026-01-05 | Titterton Lewis H jr Director | Grant or award · Employee Stock Option | +25,000 | 25,000 | ||
| 2026-01-05 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option | +350,000 | 350,000 | ||
| 2026-01-05 | Gottschalk Emily Director | Grant or award · Employee Stock Option | +25,000 | 25,000 | ||
| 2026-01-05 | Catelani Michael President, COO & CFO | Grant or award · Employee Stock Option | +175,000 | 175,000 | ||
| 2026-01-05 | Baskies Arnold M Director | Grant or award · Employee Stock Option | +25,000 | 25,000 | ||
| 2025-12-15 | Titterton Lewis H jr Director | Option exercise | +16,000 | $2.92 | $47K | 969,334 |
| 2025-12-15 | Titterton Lewis H jr Director | Option exercise · Employee Stock Option | −16,000 | 0 | ||
| 2025-10-30 | KUMAR AMIT Chief Executive Officer | Option exercise | +200,000 | $2.92 | $584K | 779,925 |
| 2025-10-30 | KUMAR AMIT Chief Executive Officer | Shares withheld for taxes | −169,439 | $4.06 | $688K | 610,486 |
| 2025-10-30 | KUMAR AMIT Chief Executive Officer | Option exercise · Employee Stock Option (Right to Buy) | −200,000 | 0 | ||
| 2025-07-31 | Titterton Lewis H jr Director | Purchase | +10,000 | $3.08 | $31K | 953,334 |
| 2025-07-30 | KUMAR AMIT Chief Executive Officer | Purchase | +5,000 | $3.16 | $16K | 579,925 |
| 2025-07-18 | Baskies Arnold M Director | Purchase | +5,000 | $3.39 | $17K | 125,000 |
| 2025-07-11 | Titterton Lewis H jr Director | Purchase | +10,000 | $3.14 | $31K | 943,334 |
| 2025-07-11 | KUMAR AMIT Chief Executive Officer | Purchase | +5,000 | $3.15 | $16K | 574,925 |
| 2025-06-04 | KUMAR AMIT Chief Executive Officer | Purchase | +10,000 | $2.85 | $29K | 569,925 |
Page 2 of 21 · 404 trades